Stay updated with breaking news from Jackd Newman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amyris, Inc. (NASDAQ:AMRS – Get Rating) has received a consensus rating of “Hold” from the nine ratings firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation and one has issued a buy recommendation on the company. The average […]
Amyris (NASDAQ:AMRS – Get Rating) had its price objective cut by equities researchers at Piper Sandler from $1.50 to $1.00 in a report issued on Wednesday, The Fly reports. Piper Sandler’s price target indicates a potential upside of 39.37% from the company’s previous close. AMRS has been the subject of several other research reports. HC […]
Wall Street brokerages forecast that Amyris, Inc. (NASDAQ:AMRS – Get Rating) will announce sales of $65.45 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have provided estimates for Amyris’ earnings, with estimates ranging from $54.90 million to $85.00 million. Amyris posted sales of $176.86 million in the same quarter last year, […]
Amyris (NASDAQ:AMRS – Get Rating) was upgraded by StockNews.com to a “sell” rating in a research note issued on Thursday. Separately, Zacks Investment Research lowered shares of Amyris from a “hold” rating to a “strong sell” rating in a research report on Thursday, March 3rd. Two research analysts have rated the stock with a sell […]
Amyris, Inc. (NASDAQ:AMRS – Get Rating) – Oppenheimer reduced their FY2024 earnings estimates for shares of Amyris in a research note issued on Tuesday, March 1st. Oppenheimer analyst C. Rusch now anticipates that the biotechnology company will earn $0.22 per share for the year, down from their prior forecast of $0.27. Amyris (NASDAQ:AMRS – Get […]